[1] |
DeTure MA, Dickson DW.The neuropathological diagnosis of Alzheimer′s disease[J]. Mol Neurodegener, 2019, 14(1):32.DOI: 10.1186/s13024-019-0333-5.
|
[2] |
|
[3] |
Yan N, Zhang J.Iron metabolism,ferroptosis,and the links with Alzheimer′s disease[J]. Front Neurosci, 2019(13):1443.DOI: 10.3389/fnins.2019.01443.
|
[4] |
Dixon SJ, Lemberg KM, Lamprecht MR,et al.Ferroptosis:an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5):1060-1072.DOI: 10.1016/j.cell.2012.03.042.
|
[5] |
Yan HF, Zou T, Tuo QZ,et al.Ferroptosis:mechanisms and links with diseases[J]. Signal Transduct Target Ther, 2021, 6(1):49.DOI: 10.1038/s41392-020-00428-9.
|
[6] |
Ashraf A, Jeandriens J, Parkes HG,et al.Iron dyshomeostasis,lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer′s disease:evidence of ferroptosis[J]. Redox Biol, 2020(32):101494.DOI: 10.1016/j.redox.2020.101494.
|
[7] |
Yang WS, Stockwell BR.Ferroptosis:death by lipid peroxidation[J]. Trends Cell Biol, 2016, 26(3):165-176.DOI: 10.1016/j.tcb.2015.10.014.
|
[8] |
Forcina GC, Dixon SJ.GPX4 at the crossroads of lipid homeostasis and ferroptosis[J]. Proteomics, 2019, 19(18):e1800311.DOI: 10.1002/pmic.201800311.
|
[9] |
Forman HJ, Zhang H, Rinna A.Glutathione:overview of its protective roles,measurement,and biosynthesis[J]. Mol Aspects Med, 2009, 30(1-2):1-12.DOI: 10.1016/j.mam.2008.08.006.
|
[10] |
Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156(1-2):317-331.DOI: 10.1016/j.cell.2013.12.010.
|
[11] |
Perluigi M, Coccia R, Butterfield DA.4-Hydroxy-2-nonenal,a reactive product of lipid peroxidation,and neurodegenerative diseases:a toxic combination illuminated by redox proteomics studies[J]. Antioxid Redox Signal, 2012, 17(11):1590-1609.DOI: 10.1089/ars.2011.4406.
|
[12] |
Bradley-Whitman MA, Lovell MA.Biomarkers of lipid peroxidation in Alzheimer disease (AD):an update[J]. Arch Toxicol, 2015, 89(7):1035-1044.DOI: 10.1007/s00204-015-1517-6.
|
[13] |
Trares K, Gào X, Perna L, et al. Associations of urinary 8-iso-prostaglandin F(2α) levels with all-cause dementia,Alzheimer′s disease,and vascular dementia incidence:results from a prospective cohort study[J]. Alzheimers Dement, 2020, 16(5):804-813.DOI: 10.1002/alz.12081.
|
[14] |
Ates G, Goldberg J, Currais A,et al.CMS121,a fatty acid synthase inhibitor,protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer′s disease[J]. Redox Biol, 2020(36):101648.DOI: 10.1016/j.redox.2020.101648.
|
[15] |
Hambright WS, Fonseca RS, Chen L,et al.Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration[J]. Redox Biol, 2017(12):8-17.DOI: 10.1016/j.redox.2017.01.021.
|
[16] |
Chen L, Dar NJ, Na R,et al.Enhanced defense against ferroptosis ameliorates cognitive impairment and reduces neurodegeneration in 5xFAD mice[J]. Free Radic Biol Med, 2022(180):1-12.DOI: 10.1016/j.freeradbiomed.2022.01.002.
|
[17] |
Tao W, Yu L, Shu S,et al.miR-204-3p/Nox4 mediates memory deficits in a mouse model of Alzheimer′s disease[J]. Mol Ther, 2021, 29(1):396-408.DOI: 10.1016/j.ymthe.2020.09.006.
|
[18] |
Luengo E, Trigo-Alonso P, Fernández-Mendívil C,et al.Implication of type 4 NADPH oxidase (NOX4) in tauopathy[J]. Redox Biol, 2022(49):102210.DOI: 10.1016/j.redox.2021.102210.
|
[19] |
Park MW, Cha HW, Kim J, et al. NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer′s diseases[J]. Redox Biol, 2021(41):101947.DOI: 10.1016/j.redox.2021.101947.
|
[20] |
McAllum EJ, Hare DJ, Volitakis I,et al.Regional iron distribution and soluble ferroprotein profiles in the healthy human brain[J]. Prog Neurobiol, 2020(186):101744.DOI: 10.1016/j.pneurobio.2019.101744.
|
[21] |
Belaidi AA, Bush AI.Iron neurochemistry in Alzheimer′s disease and Parkinson′s disease:targets for therapeutics[J]. J Neurochem, 2016(139 Suppl 1):179-197.DOI: 10.1111/jnc.13425.
|
[22] |
Ward RJ, Zucca FA, Duyn JH,et al.The role of iron in brain ageing and neurodegenerative disorders[J]. Lancet Neurol, 2014, 13(10):1045-1060.DOI: 10.1016/S1474-4422(14)70117-6.
|
[23] |
黄健,安红伟,曹诗杰.铁死亡与阿尔茨海默病的研究进展[J].中国病理生理杂志,2021,37(11):2088-93.
|
[24] |
Ayton S, Portbury S, Kalinowski P,et al.Regional brain iron associated with deterioration in Alzheimer′s disease:a large cohort study and theoretical significance[J]. Alzheimers Dement, 2021, 17(7):1244-1256.DOI: 10.1002/alz.12282.
|
[25] |
Ayton S, Diouf I, Bush AI.Evidence that iron accelerates Alzheimer′s pathology:a CSF biomarker study[J]. J Neurol Neurosurg Psychiatry, 2018, 89(5):456-460.DOI: 10.1136/jnnp-2017-316551.
|
[26] |
van Duijn S, Bulk M, van Duinen SG, et al. Cortical iron reflects severity of Alzheimer′s disease[J]. J Alzheimers Dis, 2017, 60(4):1533-1545.DOI: 10.3233/JAD-161143.
|
[27] |
Serrano-Pozo A, Das S, Hyman BT. APOE and Alzheimer′s disease:advances in genetics,pathophysiology,and therapeutic approaches[J]. Lancet Neurol, 2021, 20(1):68-80.DOI: 10.1016/S1474-4422(20)30412-9.
|
[28] |
van Bergen JM, Li X, Hua J,et al.Colocalization of cerebral iron with Amyloid beta in mild cognitive impairment[J]. Sci Rep, 2016(6):35514.DOI: 10.1038/srep35514.
|
[29] |
Ayton S, Faux NG, Bush AI. Ferritin levels in the cerebrospinal fluid predict Alzheimer′s disease outcomes and are regulated by APOE[J]. Nat Commun, 2015(6):6760.DOI: 10.1038/ncomms7760.
|
[30] |
Zhang DL, Wu J, Shah BN,et al.Erythrocytic ferroportin reduces intracellular iron accumulation,hemolysis,and malaria risk[J]. Science, 2018, 359(6383):1520-1523.DOI: 10.1126/science.aal2022.
|
[31] |
Bao WD, Pang P, Zhou XT,et al.Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer′s disease[J]. Cell Death Differ, 2021, 28(5):1548-1562.DOI: 10.1038/s41418-020-00685-9.
|
[32] |
Mancias JD, Wang X, Gygi SP,et al.Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy[J]. Nature, 2014, 509(7498):105-109.DOI: 10.1038/nature13148.
|
[33] |
Fujii J, Homma T, Kobayashi S. Ferroptosis caused by cysteine insufficiency and oxidative insult[J]. Free Radic Res, 2020, 54(11-12):969-980.DOI: 10.1080/10715762.2019.1666983.
|
[34] |
Latunde-Dada GO.Ferroptosis:role of lipid peroxidation,iron and ferritinophagy[J]. Biochim Biophys Acta Gen Subj, 2017, 1861(8):1893-1900.DOI: 10.1016/j.bbagen.2017.05.019.
|
[35] |
Hoxhaj G, Manning BD.The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism[J]. Nat Rev Cancer, 2020, 20(2):74-88.DOI: 10.1038/s41568-019-0216-7.
|
[36] |
Belaidi AA, Masaldan S, Southon A,et al.Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy[J/OL]. Mol Psychiatry, 2022:E1[2022-06-29].published online ahead of print April 28,2022].DOI: 10.1038/s41380-022-01568-w.
URL
|
[37] |
Tian Y, Lu J, Hao X,et al.FTH1 inhibits ferroptosis through ferritinophagy in the 6-OHDA model of parkinson′s disease[J]. Neurotherapeutics, 2020, 17(4):1796-1812.DOI: 10.1007/s13311-020-00929-z.
|
[38] |
Zuo Y, Xie J, Li X, et al. Ferritinophagy-mediated ferroptosis involved in paraquat-induced neurotoxicity of dopaminergic neurons:implication for neurotoxicity in PD[J]. Oxid Med Cell Longev, 2021(2021):9961628.DOI: 10.1155/2021/9961628.
|
[39] |
Xiao J, Zhang S, Tu B,et al.Arsenite induces ferroptosis in the neuronal cells via activation of ferritinophagy[J]. Food Chem Toxicol, 2021(151):112114.DOI: 10.1016/j.fct.2021.112114.
|
[40] |
Gao S, Jin Y, Hall KS,et al.Selenium level and cognitive function in rural elderly Chinese[J]. Am J Epidemiol, 2007, 165(8):955-965.DOI: 10.1093/aje/kwk073.
|
[41] |
Akbaraly TN, Hininger-Favier I, Carrière I,et al.Plasma selenium over time and cognitive decline in the elderly[J]. Epidemiology, 2007, 18(1):52-58.DOI: 10.1097/01.ede.0000248202.83695.4e.
|
[42] |
Cardoso BR, Ong TP, Jacob-Filho W, et al. Nutritional status of selenium in Alzheimer′s disease patients[J]. Br J Nutr, 2010, 103(6):803-806.DOI: 10.1017/S0007114509992832.
|
[43] |
Xia X, Zhang X, Liu M, et al. Toward improved human health:efficacy of dietary selenium on immunity at the cellular level[J]. Food & function, 2021, 12(3):976-989.DOI: 10.1039/d0fo03067h.
|
[44] |
|
[45] |
Ingold I, Berndt C, Schmitt S,et al.Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis[J]. Cell, 2018, 172(3):409-422.e21.DOI: 10.1016/j.cell.2017.11.048.
|
[46] |
Tuo QZ, Masaldan S, Southon A,et al.Characterization of selenium compounds for anti-ferroptotic activity in neuronal cells and after cerebral ischemia-reperfusion injury[J]. Neurotherapeutics, 2021, 18(4):2682-2691.DOI: 10.1007/s13311-021-01111-9.
|
[47] |
Yao Y, Chen Z, Zhang H,et al.Selenium-GPX4 axis protects follicular helper T cells from ferroptosis[J]. Nat Immunol, 2021, 22(9):1127-1139.DOI: 10.1038/s41590-021-00996-0.
|
[48] |
Leiter O, Zhuo Z, Rust R,et al.Selenium mediates exercise-induced adult neurogenesis and reverses learning deficits induced by hippocampal injury and aging[J]. Cell Metab, 2022, 34(3):408-423.e8.DOI: 10.1016/j.cmet.2022.01.005.
|
[49] |
Li Z, Ferguson L, Deol KK,et al.Ribosome stalling during selenoprotein translation exposes a ferroptosis vulnerability[J]. Nat Chem Biol, 2022, 18(7):751-761.DOI: 10.1038/s41589-022-01033-3.
|
[50] |
Zhang Y, Zhou Y, Schweizer U, et al. Comparative analysis of selenocysteine machinery and selenoproteome gene expression in mouse brain identifies neurons as key functional sites of selenium in mammals[J]. J Biol Chem, 2008, 283(4):2427-2438.DOI: 10.1074/jbc.M707951200.
|
[51] |
Solovyev N, Drobyshev E, Bjørklund G,et al.Selenium,selenoprotein P,and Alzheimer′s disease:is there a link?[J]. Free Radic Biol Med, 2018(127):124-133.DOI: 10.1016/j.freeradbiomed.2018.02.030.
|
[52] |
Shepherd C, McCann H, Halliday GM.Variations in the neuropathology of familial Alzheimer′s disease[J]. Acta Neuropathol, 2009, 118(1):37-52.DOI: 10.1007/s00401-009-0521-4.
|
[53] |
Greenough MA, Lane D, Balez R,et al.Selective ferroptosis vulner-ability due to familial Alzheimer′s disease presenilin mutations[J/OL]. Cell Death Differ, 2022:E1[2022-06-29].published online ahead of print April 21,2022].DOI: 10.1038/s41418-022-01003-1.
URL
|
[54] |
Wang Y, Yan S, Liu X,et al.PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway[J/OL]. Cell Death Differ, 2022:E1[2022-06-29].published online ahead of print April 5,2022].DOI: 10.1038/s41418-022-00990-5.
URL
|
[55] |
Wang CY, Zhang Q, Xun Z,et al.Increases of iASPP-Keap1 interaction mediated by syringin enhance synaptic plasticity and rescue cognitive impairments via stabilizing Nrf2 in Alzheimer′s models[J]. Redox Biol, 2020(36):101672.DOI: 10.1016/j.redox.2020.101672.
|
[56] |
Robert A, Liu Y, Nguyen M,et al.Regulation of copper and iron homeostasis by metal chelators:a possible chemotherapy for Alzheimer′s disease[J]. Acc Chem Res, 2015, 48(5):1332-1339.DOI: 10.1021/acs.accounts.5b00119.
|
[57] |
Wu Z, Palanimuthu D, Braidy N,et al.Novel multifunctional iron chelators of the aroyl nicotinoyl hydrazone class that markedly enhance cellular NAD(+) /NADH ratios[J]. Br J Pharmacol, 2020, 177(9):1967-1987.DOI: 10.1111/bph.14963.
|
[58] |
Tamtaji OR, Heidari-Soureshjani R, Mirhosseini N,et al.Probiotic and selenium co-supplementation,and the effects on clinical,metabolic and genetic status in Alzheimer′s disease:a randomized,double-blind,controlled trial[J]. Clin Nutr, 2019, 38(6):2569-2575.DOI: 10.1016/j.clnu.2018.11.034.
|
[59] |
van Eersel J, Ke YD, Liu X,et al.Sodium selenate mitigates tau pathology,neurodegeneration, and functional deficits in Alzheimer′s disease models[J]. Proc Natl Acad Sci USA, 2010, 107(31):13888-13893.DOI: 10.1073/pnas.1009038107.
|
[60] |
Kryscio RJ, Abner EL, Caban-Holt A, et al.Association of antioxidant supplement use and dementia in the prevention of alzheimer′s disease by vitamin E and selenium trial (PREADViSE)[J]. JAMA neurology, 2017, 74(5):567-573.DOI: 10.1001/jamaneurol.2016.5778.
|